Last reviewed · How we verify
probiotic containing L.rhamnosus R0011 strain
At a glance
| Generic name | probiotic containing L.rhamnosus R0011 strain |
|---|---|
| Also known as | L rhamnosus R0011 |
| Sponsor | University of Michigan |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Encapsulated Probiotics & Gut Microbiota (PHASE1)
- Use of Probiotics as Adjunctive Treatment for Chronic Rhinosinusitis (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: